Health empowerment and information literacy program for people with metabolic syndrome

Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome

Not applicable Interventional Capital Medical University · NCT07096102

This program will try to improve how adults with metabolic syndrome find and use health information and support better self-care through training, peer support, and online coaching.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment310 (estimated)
Ages18 Years to 75 Years
SexAll
SponsorCapital Medical University Academic / other
Locations4 sites (Beijing, Beijing Municipality and 3 other locations)
Trial IDNCT07096102 on ClinicalTrials.gov

What this trial studies

The intervention delivers a 6-week combination of face-to-face and online sessions offering health information literacy training, medication and self-monitoring skills, diet and exercise education, personalized goal setting, incentives, and peer support. Participants are assigned to the ENRICH intervention or routine care and are regularly assessed for changes in health information literacy and metabolic health indicators. Weekly WeChat Q&A, family/community involvement, and role-model activities are used to reinforce learning and behavior change. Primary outcomes include literacy measures and clinical endpoints such as weight, waist circumference, BMI, blood pressure, blood glucose, HbA1c, and blood lipids.

Who should consider this trial

Good fit: Adults aged 18–75 with metabolic syndrome meeting at least three diagnostic criteria who are aware of their condition and have basic reading and communication skills are ideal candidates.

Not a fit: Individuals with severe liver or kidney dysfunction, active cancer, major cardiovascular or cerebrovascular disease, pregnancy, cognitive impairment, or those already enrolled in other research are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, the program could help people with metabolic syndrome better manage their condition and improve weight, blood pressure, blood sugar, and cholesterol through improved knowledge and self-care.

How similar studies have performed: Similar health empowerment and literacy programs have improved knowledge and self-care in chronic conditions, although effects on metabolic biomarkers have been mixed.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years old and ≤ 75 years old;;
* Patients diagnosed with metabolic syndrome (meeting ≥3 criteria):
* Waist circumference ≥ 90 cm (men) / ≥ 85 cm (women)
* Fasting glucose ≥ 6.1 mmol/L or OGTT 2h-glucose ≥ 7.8 mmol/L and/or diabetes treatment
* Blood pressure ≥ 130/85 mmHg and/or hypertension treatment
* Fasting triglycerides (TG) ≥ 1.70 mmol/L
* Fasting HDL-C \< 1.04 mmol/L;
* Aware of the condition, have basic reading and language communication skills, and voluntarily participate in this study

Exclusion Criteria:

* Patients with severe liver and kidney dysfunction, cancer, severe cardiovascular and cerebrovascular diseases, gout, etc., which seriously endanger life, have abnormal nutritional status and require special diet;
* Pregnant patients;
* Patients with a history of mental illness and cognitive impairment;
* Those currently participating in other research projects.

Where this trial is running

Beijing, Beijing Municipality and 3 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Metabolic Syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.